Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Suven Granted Two Patents for New Neuro Drug Candidates

publication date: May 21, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Suven Life Sciences Ltd, headquartered in Hyderabad, India, was granted patents In China and South Africa for two new chemical entities (NCEs) that treat disorders associated with neuro-degenerative diseases. Both NCEs belong to the class of selective 5-HT compounds. They are being developed as therapeutic agents for the treatment of cognitive impairment. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors